Risk adjusted net present value: What is the current valuation of Aquestive Therapeutics’s Epinephrine?
Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis.
Epinephrine is a small molecule commercialized by Aquestive Therapeutics, with a leading Phase III program in Anaphylaxis.
What's Your Reaction?
